United States HR 4866: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Status: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (as of 2020-09-22)

State: United States · Session: 116 · Bill: HR 4866

Subjects: Advanced technology and technological innovations, Congressional oversight, Drug safety, medical device, and laboratory regulation, Government information and archives, Health programs administration and funding, Health technology, devices, supplies, Higher education, Manufacturing, Prescription drugs, Product development and innovation, Research administration and funding, Research and development

Sponsors: FRANK PALLONE, Abigail Davis Spanberger, Brett Guthrie

View United States HR 4866 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.